AVDL
USDAvadel Pharmaceuticals plc Ordinary Share
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$18.750
High
$18.780
Low
$18.680
Volume
1.08M
Company Fundamentals
Market Cap
1.8B
Industry
Drug Manufacturers - Specialty & Generic
Country
Ireland
Trading Stats
Avg Volume
2.43M
Exchange
NGM
Currency
USD
52-Week Range
Related News
UBS Downgrades Avadel Pharmaceuticals to Neutral, Maintains Price Target to $20
UBS analyst Ashwani Verma downgrades Avadel Pharmaceuticals from Buy to Neutral and maintains the price target from $20 to $20.
Leerink Partners Downgrades Avadel Pharmaceuticals to Market Perform, Announces $18.5 Price Target
Leerink Partners analyst Marc Goodman downgrades Avadel Pharmaceuticals from Outperform to Market Perform and announces $18.5 price target.
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL)
Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...
HALPER SADEH LLC ENCOURAGES AVDL, MBCN, FMNB SHAREHOLDERS TO ENFORCE THEIR RIGHTS AND CONTACT THE LAW FIRM
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Jefferies Downgrades Avadel Pharmaceuticals to Hold, Lowers Price Target to $20
Jefferies analyst Andrew Tsai downgrades Avadel Pharmaceuticals from Buy to Hold and lowers the price target from $22 to $20.
Needham Downgrades Avadel Pharmaceuticals to Hold
Needham analyst Ami Fadia downgrades Avadel Pharmaceuticals from Buy to Hold.
Avadel Pharmaceuticals and Jazz Pharmaceuticals Reach Global Settlement
DUBLIN, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settlement of all
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.